Dr. Münter is a Lead Research Scientist with the Vaccine Adjuvant Systems R&D Department of Croda Pharma, based in Denmark. He holds a masters degree in Nanoscience from University of Copenhagen and a PhD degree in Drug Delivery from the Technical University of Denmark (DTU). He has extensive knowledge in how lipid nanoparticles for drug delivery interact with the immune system and blood components. In his previous role at DTU, he participated in development of RNA therapeutics for cancer immunotherapy and in situ CAR T cell generation. In his current position, he is responsible for functional immunological testing of novel vaccine adjuvant systems including RNA vaccines.